# Efficacy and Safety Study of Entecavir Plus Tenofovir in Patients With Chronic Hepatitis B Who Failed Previous Treatment

> **NCT01063036** · PHASE3 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 144 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** Entecavir
- **DRUG:** Tenofovir

## Key facts

- **NCT ID:** NCT01063036
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2012-11
- **Final completion:** 2014-02
- **Target enrollment:** 144 (ACTUAL)
- **Last updated:** 2014-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01063036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01063036, "Efficacy and Safety Study of Entecavir Plus Tenofovir in Patients With Chronic Hepatitis B Who Failed Previous Treatment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01063036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*